CNS agents, J.M. McCall; new anxiolytics, L.J. Browne and K.J. Shaw; recent advances in excitatory amino acid research, G.Johnson and C.F. Bigge; progress in anti-depressant drugs, D.W. Robertson and R.W. Fuller; diversity of neuronal calcium channels, N.A. Saccomano and A.H. Ganong; recent advances in neurokinin receptor anatagonists, M.E. Logan, et al; antipsychotics, L.D. Wise and T.G. Heffner; cardiovascular and pulmonary agents, D.W. Robertson; angiotensin/renin modulators, W.J. Greenlee and P.K.S. Siegl; potassium channel activators, J.M. Evans and S.D. Longman; endogenous vasoactive peptides, A.M. Doherty; emerging drug discovery targets in thrombosis and coagulation, R.J. Shebuski; serotonin modulators and cardiovascular/gastrointestinal disease, J.E. Audia and M.L. Cohen; pulmonary and anti-allergy agents, D.J. Wolanin and J.B. Campbell; chemotherapeutic agents, J.J. Plattner; antibacterial agents, K.E. Brighty and P.R. McGuirk; antiviral agents, M.M. Mansuri and J.C. Martin; HIV protease inhibitors, D.W. Norbeck and D.J. Kempf; radiosensitizers, M.J. Suto; antiparasitic agents, D.M. Schmatz and J.M. Schaeffer; function of human retrovirus regulatory proteins, C.A. Rosen and S.M. Ruben; immunology, endocrinology and metabolic diseases, W.F. Michne; chemical basis for immune mediated idiosyncratic drug hypersensitivity, M.A. Sanner and T.J. Higgins; cholecystokinin agonists and antagonists, A.M. Nadzan and J.F. Kerwin; recent advances in bone metabolism and osteoporosis research, T.J. Caggiano, et al; mechanism-based immunosuppressants, J.R. Luly; topics in biology, K.B. Seamon; cytokin receptors, D.L. Urdal; amyloidogenesis as a therapeutic target in Alzheimer's disease, B.D. Greenberg and F.J. Kezdy; bacterial adhesins, J. London; regulation of the ras GTPase cycle, G. Bollag, et al; topics in drug design and discovery, M.C. Venuti; the search for molecular diversity (1) natural products, L.J. Nisbet and P.J. Hylands; the search for molecular diversity (2) recombinant and synthetic randomized peptide libraries, W.J. Dower and S.P.A. Fodor; receptor modeling by distance geometry, J.M. Blaney and J.S. Dixon; sequence-defined oligonucleotides as potential therapeutics, M.D. Matteucci and N. Bischofberger; trends and perspectives, J.A. Bristol; to market, to market - 1990, J.D. Strupczewski, et al; perspectives on human gene therapy, G.J. Nabel and E.G. Nabel.